Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2020 Earnings Conference Call May 8, 2020 8:00 AM ET Company Participants Sarah Carmody ??? Executive Director-Investor Relations and Corporate Communications Anna Protopapas ??? President and Chief Executive Officer Dirk Huebner ??? Chief Medical Officer Tim Lowinger ??? Chief Science and Technology Officer Brian DeSchuytner ??? Senior Vice President-Finance and Product Strategy Eva Jack ??? Chief Business Officer Conference Call Participants Jonathan Chang ??? S ...

T H E R A P E U T I C S Accelerating ADC Innovation …because patients are waiting March 2020 Legal Disclaimer This presentation contains "forward-looking" statements within the meaning of federal securities laws. These forward-looking statements are not statements of historical facts and are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the Company's business strategy and the design, progression a ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2019 Results Conference Call February 28, 2020 8:00 AM ET Company Participants Sarah Carmody - Executive Director, IR and Corporate Communications Anna Protopapas - CEO Brian DeSchuytner - SVP, Finance and Product Strategy Conference Call Participants Jonathan Chang - SVB Leerink Boris Peaker - Cowen Debjit Chattopadhyay - H.C. Wainwright Jessica Fye - JP Morgan Mike Ulz - Baird David Nierengarten - Wedbush Securities Operator Good morning, and welcome to Mersana ...

THERAPEUTICS Accelerating ADC Innovation …because patients are waiting 38th Annual JP Morgan Healthcare Conference January 16, 2020 Legal Disclaimer This presentation contains "forward-looking" statements within the meaning of federal securities laws. These forward-looking statements are not statements of historical facts and are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the Company's business ...

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2019 Earnings Conference Call November 6, 2019 8:00 AM ET Company Participants Sarah Carmody - Executive Director, IR & Corporate Communications Anna Protopapas - President, CEO & Director Dirk Huebner - Chief Medical Officer Timothy Lowinger - Chief Science & Technology Officer Brian DeSchuytner - SVP, Finance & Product Strategy Conference Call Participants Jonathan Chang - SVB Leerink Earl DeSouza - H.C. Wainwright & Co. Boris Peaker - Cowen and Company Daniel W ...